GlassScriptPhysician profile
Tara Wilson
NPI 1922176429
$17,849.86
in general payments reported to CMS, 2019-2025
21 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $20.88 · 2021: $194 · 2022: $125 · 2023: $258 · 2024: $1,183 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $2,606 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $451 · Gift: $14.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $2,605.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $450.72 |
| Gift | $14.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,083.42 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $537.31 | 2021-2024 | Myrisk |
| Smith+Nephew, INC. | $261.57 | 2019-2025 | Stravix Pl, Grafix Pl, Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $203.24 | 2024-2025 | Imfinzi, Enhertu, Calquence |
| W. L. Gore & Associates, INC. | $123.05 | 2019 | |
| Medline Industries LP | $103.06 | 2019 | |
| Medtronic, INC. | $65.67 | 2023 | Progrip |
| Tei Biosciences INC | $54.78 | 2019 | |
| Allergan, INC. | $48.37 | 2019 | |
| Solventum Corporation | $47.89 | 2024-2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.12 | 2019 | |
| Abiomed | $44.80 | 2025 | |
| Davol INC. | $43.96 | 2024-2025 | Arista, Phasix Mesh |
| Shire North American Group INC | $34.84 | 2019 | |
| Elucent Medical | $27.17 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $24.51 | 2025 | Enhertu |
| Lilly USA, LLC | $24.44 | 2024 | Verzenio, Retevmo, Jaypirca |
| Acera Surgical, INC. | $22.22 | 2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $20.88 | 2020 | |
| Leica Microsystems INC. | $18.65 | 2022 | |
| Puma Biotechnology, INC. | $14.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.